Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALS biomarker research using patient clinical samples
jRCTs051180229Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bosutinib in amyotrophic lateral sclerosis (ALS), sponsored by Japan Agency for Medical Research and Development. Started Apr 2019; status: recruiting.
02
Drugs
bosutinib
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on jRCTs051180229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180229.